$COSMJun 5, 2026, 1:25 PMAI processed
COSM launches Oliv18 olive polyphenol supplement in U.S., targets cardiovascular & antioxidant markets
AI Summary
Cosmos Health (COSM) launched Oliv18, a USDA- and EU-organic certified, 100% solvent-free whole olive polyphenol supplement in the U.S., standardized to hydroxytyrosol and oleuropein with a 250 mg daily dose that meets EFSA's 5 mg/day hydroxytyrosol threshold for LDL oxidation protection. The product is positioned in the company’s premium 18 Series to target the large and growing cardiovascular and antioxidant supplement markets (combined global market projection cited >$33B by 2035).
Positives
- 250 mg daily dose meets EFSA 5 mg/day hydroxytyrosol threshold for LDL oxidation protection
- USDA & EU organic certified and produced via 100% solvent-free process, supporting premium positioning
- Targets large markets: company cites combined cardiovascular and antioxidant market >$33B by 2035
Negatives
- No clinical trial data or independent efficacy results presented in the announcement
- Product is a dietary supplement and claims have not been evaluated by the FDA
- No details disclosed on U.S. distribution partners, pricing, or near-term revenue impact
